Stock A002720 KUKJE PHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Kukje Pharma Co., Ltd.

Equities

A002720

KR7002720001

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-29 EDT 		5-day change 1st Jan Change
4,710 KRW -1.67% Intraday chart for Kukje Pharma Co., Ltd. -2.79% -20.44%
05-16 Kukje Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-18 Kukje Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Kukje Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Kukje Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Kukje Pharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Kukje Pharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Kukje Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Kukje Pharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Kukje Pharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Kukje Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Kukje Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
OncoPep, Inc. announced that it has received $11 million in funding from TERA SCIENCE Co.,LTD, Crystal Bioscience Inc., Kukje Pharma Co., Ltd.
CI
Kukje Pharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Coronavirus infects Asia stocks with exposure to China
RE
ASX 200 : Coronavirus infects Asia stocks with exposure to China
RE
Tranche Update on Kukje Pharmaceutical Industrial Co. Ltd.'s Equity Buyback Plan announced on November 2, 2016.
CI
Kukje Pharmaceutical Industrial Co. Ltd.'s Equity Buyback announced on November 2, 2016, has closed with 300,000 shares, representing 1.81% for KRW 1,371.73 million.
CI
Kukje Pharmaceutical Industrial Co. Ltd. authorizes a Buyback Plan.
CI
Kukje Pharmaceutical Industrial Co. Ltd. announces an Equity Buyback for 300,000 shares.
CI
Kukje Pharmaceutical Industrial Co. Ltd. and other buyers cancelled the acquisition of partial stake in cosmetics business from Kukje Pharmaceutical Industrial Co. Ltd.
CI
Kukje Pharmaceutical Industrial Co. Ltd. and other buyers agreed to acquire partial stake in cosmetics business from Kukje Pharmaceutical Industrial Co. Ltd. for KRW 2 billion.
CI
Kukje Pharmaceutical Industrial Co. Ltd.’s Equity Buyback announced on August 9, 1994 has expired.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A002720 Stock
  4. News Kukje Pharma Co., Ltd.